slides · global inventory
Expose Contradiction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 14,162
Current window 10,501-10,530
Pages 473
Rows per page 30
Slide function
10,501-10,530 of 14,162
127
The slide uses a combination of narrative summary and direct excerpts from a Feb 2024 letter to expose flaws in the OPTN allocation system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
128
The slide presents anecdotal evidence of systemic gaming of the organ allocation system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
129
The slide uses a direct quote from a transplant surgeon to allege systemic gaming of the organ allocation system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
131
The slide uses a Q&A transcript format to highlight a competitor's critique of the subject company's business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
133
The slide presents a narrative of systemic corruption and regulatory bypass involving TransMedics and OPOs.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
134
The slide uses a Q&A format to document expert testimony regarding potential kickbacks and regulatory circumvention.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
135
The slide uses a Q&A format to highlight alleged unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
136
The slide uses highlighted quotes from transplant surgeons to build a case for potential regulatory or ethical issues regarding TransMedics' business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
137
The slide uses a Q&A format to highlight a specific allegation of unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
140
The slide uses a Q&A format to provide direct evidence of unethical behavior in the organ transplant system.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
141
The slide uses a Q&A format to highlight alleged procedural violations. The yellow highlighting emphasizes the specific claims of bypassing the OPO.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
142
Includes a Q&A transcript excerpt highlighting potential ethical/regulatory concerns regarding organ allocation and communication methods.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
143
The slide uses a 'smoking gun' narrative to frame the testimonial as evidence of unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
144
Includes a Q&A transcript excerpt as evidence for the allegations.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
145
The slide uses a Q&A format to present testimony from an industry veteran, highlighting allegations of unethical sales practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
146
The slide uses a Q&A format to highlight potential regulatory violations by TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
147
The slide uses a combination of summary text and a direct quote from a high-volume user to substantiate the claim of unethical organ allocation practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
148
The slide uses a Q&A format to highlight alleged unethical business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
149
The slide uses screenshots of the UNOS/UNet portal to establish the system's official status and legal warnings.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
150
The slide uses a Q&A transcript format to highlight potential ethical concerns regarding vendor access to sensitive medical data.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
151
The slide presents two Q&A excerpts from a transplant surgeon to support the claim that TransMedics is hijacking the organ allocation process.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
152
The slide uses direct quotes from industry experts to build a case against TransMedics' business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
153
The slide uses a Q&A format to highlight potential misuse of system access.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
155
The slide uses a 'fraud-exposure' framework to contrast alleged real-world usage with official FDA labeling.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
156
The slide uses a combination of qualitative expert interview summaries and quantitative data from the company's own investor presentation to frame the company's clinical claims as a 'ruse'.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
157
The slide uses a testimonial to undermine the corporate narrative of 'Game Changer' technology, suggesting it is instead a tool for labor convenience.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
158
The slide uses a testimonial/interview format to challenge the necessity of the OCS device for local transplants.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
159
The slide uses Q&A transcripts to undermine a business model premise.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
160
The slide uses direct quotes from transplant directors to challenge the value proposition of TransMedics' NOP service.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
162
The slide uses a Q&A format to present expert testimony regarding potential misuse of medical devices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit